NP Allies Return to NPA Main Site

Treatment overview

Hyperbaric Oxygen Therapy (HBOT)

Hyperbaric oxygen therapy involves breathing pure oxygen inside a pressurized chamber so that plasma and tissues absorb substantially more oxygen than under normal conditions. A typical course for investigational neurological uses consists of daily or near-daily 60–90-minute sessions over several weeks.

Overview

What It Is Hyperbaric oxygen therapy involves breathing pure oxygen inside a pressurized chamber so that blood and tissues absorb substantially more oxygen than normal. It is an established treatment for certain approved indications and has also been studied for brain injury and cognitive symptoms.

How It Works Higher oxygen availability can support tissue healing and cellular energy production in injured areas. In the brain, proposed benefits include reduced inflammation and support for repair processes that may allow remaining networks to function better. Whether this translates into lasting cognitive gains after chronic brain injury remains an active research question.

Conditions - FDA-cleared / established uses: decompression sickness, selected problem wounds, carbon-monoxide poisoning, and other approved indications. - Also studied for (off-label / mixed evidence): chronic traumatic brain injury and cognitive symptoms. - Note: Insurance coverage is generally restricted to approved indications. Risks include barotrauma and, rarely, oxygen toxicity; medical screening is required.

How it is administered

In-clinic sessions inside a pressurized hyperbaric chamber. Sessions typically last 60–90 minutes; courses for neurological applications often involve 20–40 sessions over several weeks.

The NPA Treatment Database lists this treatment in connection with 6 condition records. A database relationship does not establish effectiveness, safety, or suitability for an individual.

These controlled question pages reference this treatment through stored condition relationships.

Symptoms connected in the NPA database

The current record associates this treatment with the following symptom information. This is not a claim that the treatment will improve these symptoms.

Cognition & Memory

  • confusion with time/place
  • difficulty concentrating
  • difficulty with familiar tasks
  • difficulty with flexible thinking
  • intense focus on specific interests
  • Later memory and thinking changes
  • memory
  • Memory loss (especially recent events)
  • mental fog
  • multitasking difficulty
  • Problems with concentration
  • Short-term memory issues
  • Short-term memory problems
  • slowed mental processing
  • slowed processing
  • slowed thinking
  • spatial neglect
  • trouble planning or problem-solving
  • Variable cognitive strengths/challenges

Emotion & Behavior

  • anxiety
  • apathy
  • Challenges with social communication
  • Depression
  • emotional control issues
  • emotional lability (uncontrollable laughing/crying)
  • emotional regulation differences
  • impulsivity
  • irritability
  • Mood and personality changes
  • mood changes
  • mood swings
  • repetitive behaviors
  • restricted interests
  • withdrawal from activities

Practical information

Insurance coverage

Covered by insurance for certain FDA-approved indications (e.g., decompression sickness, carbon monoxide poisoning, some wounds). Rarely covered for chronic TBI or cognitive decline.

Cost information

$200–$400+ per session. Full courses often $5,000–$15,000+ out of pocket when not covered.

Results and outcomes described in the source record

Some people report improvements during or shortly after a course of 20–40 sessions; durability varies.

Side effects and risks

Risks include ear/sinus barotrauma, temporary vision changes, claustrophobia, and rare more serious events (oxygen toxicity, lung issues). Requires medical screening.

Research context in the NPA database

This section reproduces the current database's research summary and detail. Structured citation metadata has not been supplied, so it should not be read as an independently verified literature review.

Research summary

Evidence Level: Mixed / Emerging (for brain injury)

What the research shows: HBOT is established for certain approved medical conditions. For chronic brain injury and cognitive symptoms, study results are mixed and mainstream acceptance remains limited.

Key takeaway: An intensive, clinic-based treatment that may be considered in selected cases, ideally within research or carefully monitored settings.

Research detail

Overview Hyperbaric oxygen therapy involves breathing pure oxygen inside a pressurized chamber so that plasma and tissues absorb substantially more oxygen than under normal conditions. It is an established treatment for certain approved indications (e.g., decompression sickness, selected wounds, carbon-monoxide poisoning) and has been explored for brain injury and cognitive symptoms. A typical course for investigational neurological uses consists of daily or near-daily 60–90-minute sessions over several weeks.

Evidence Base and Published Work • HBOT is established for certain FDA-cleared indications (decompression sickness, selected wounds, carbon-monoxide poisoning). • For chronic traumatic brain injury and cognitive symptoms, randomized trial results are mixed and systematic reviews frequently note methodological limitations. Acceptance and insurance coverage for neurological applications remain more limited than for approved indications. • Key published work includes: – Mixed RCT results for chronic TBI. – Stronger evidence for approved non-neurological indications. – Systematic reviews noting methodological limitations for neurological applications. – Risks include ear/sinus barotrauma, temporary vision changes, claustrophobia, and rare more serious events (oxygen toxicity, lung issues); medical screening is required. Insurance coverage is generally restricted to approved indications.

Outcomes for approved indications are well-established. For chronic brain injury and cognitive symptoms, study results are mixed and mainstream acceptance remains limited. The treatment is intensive and clinic-based.

Questions to ask a provider

1. Is HBOT being recommended for an FDA-cleared indication in my case, or for an off-label neurological use? 2. How many sessions are proposed, at what pressure and duration, and over what timeframe? 3. What medical screening will I complete, and what are the risks (barotrauma, oxygen toxicity, claustrophobia)? 4. What evidence exists for HBOT for my specific condition, and what outcomes are realistic? 5. Will insurance cover the course of treatment, and what is the total out-of-pocket cost if not?

Explore the interactive Treatment Database

Continue to compare educational treatment information in the interactive database. The standard disclaimer acknowledgement is required before the database opens.

Explore treatment information in the database

Educational information disclaimer

The information provided in this app is for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment, and should not be relied upon as a substitute for professional medical care.

Treatments, therapies, and interventions described here may not be appropriate for every person or condition. Evidence levels, availability, costs, insurance coverage, and risks can vary. Nothing in this app constitutes a recommendation that you start, stop, or change any treatment.

Always consult your physician, neurologist, or other qualified healthcare provider before beginning any new therapy, device, program, or intervention, and before making decisions about your care. Seek prompt medical attention for any urgent or emergency symptoms. By using this app, you acknowledge that NP Allies and its contributors are not responsible for any decisions you make based on the information provided, or for any outcomes that result from those decisions.